ArticleMedical oncology (Northwood, London, England)2026
Phyllanthus niruri potentiates apoptosis in Huh-7 cells and mitigates diethylnitrosamine-induced hepatocarcinogenesis via Hippo-YAP pathway modulation.
Article in Medical oncology (Northwood, London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Hepatocellular carcinoma is one of the deadliest cancers occurring worldwide. Substantial evidence suggests that the Hippo-YAP pathway as a promising therapeutic target. Phyllanthus niruri is known for pharmacological activities, including hepatoprotective, anti-viral, and anti-inflammatory effects. However, there is a lacuna of molecular studies on how the bioactives in Phyllanthus niruri interacts with hippo signaling to enhance its potential for liver cancer management. This study aimed to delineate the effects of Phyllanthus niruri extract on cell proliferation and apoptosis, and its mechanisms in modulating the Hippo-YAP signaling, using Huh-7 cells and a diethylnitrosamine-induced liver cancer model in Wistar rats. MTT assay results confirmed that Phyllanthus niruri reduced the viability of Huh-7 cells in a dose-dependent manner. Notably, Phyllanthus niruri extracts decreased nuclear YAP-localization by modulating upstream regulators of the Hippo-YAP pathway and promoted apoptosis, as evidenced by increased ROS levels and the upregulation of Bax and downregulation Bcl-2 protein expression. In diethylnitrosamine-induced liver cancer rats, oral administration of Phyllanthus niruri extract significantly reduced tumor burden, activated hippo signaling, and exhibited therapeutic effects. Overall, Phyllanthus niruri extracts exhibited anti-proliferative, and pro-apoptotic effects in experimental liver cancer models offering valuable insights into their mechanism of action through modulation of the Hippo-YAP signaling pathway.
Indexed as
Identifiers
41524810What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.